CeriBell Inc. Company Profile
NASDAQ: CBLLHealthcareMedical DevicesUSD
At close: Oct 7, 4:00 PM ET · Delayed 15 min
CeriBell at a glance
CeriBell Inc. (NASDAQ: CBLL) is a Medical Devices company in the Healthcare sector headquartered in Sunnyvale, CA. CeriBell is led by Dr. Xingjuan Chao Ph.D. and employs about 327 people. The company's shares have traded publicly since 2024.
At a market capitalization of $901.1 million, it is considered a small-cap company. Its SEC Central Index Key (CIK) is 0001861107, which identifies the company's filings on EDGAR.
Summary generated from market data by MetaCap's automated system. Methodology
What does CeriBell do?
CeriBell, Inc. operates as a medical technology company in the United States. It develops the Ceribell System, a novel and point-of-care EEG platform specifically designed to address the unmet needs of patients in the acute care setting. The company also offers disposable, flexible headbands, and headcaps; and a pocket-sized, rechargeable battery-operated recorder used to capture and wirelessly transmit EEG signals; and Clarity, an AI-powered seizure detection algorithm. In addition, it operates an EEG portal, which enables real-time remote access to a patient's EEG data. The company was formerly known as Brain Stethoscope, Inc. and changed its name to CeriBell, Inc. in August 2015. CeriBell, Inc. was incorporated in 2014 and is headquartered in Sunnyvale, California.
Business description based on the company's public filings.
Company information
- Legal name
- CeriBell Inc.
- Ticker
- NASDAQ: CBLL
- Sector
- Healthcare
- Industry
- Medical Devices
- CEO
- Dr. Xingjuan Chao Ph.D.
- Employees
- 327
- Headquarters
- 360 North Pastoria Avenue, Sunnyvale, CA, United States
- Phone
- 800 436 0826
- Website
- ceribell.com
- IPO year
- 2024
- Market cap
- $901.12M
- SEC CIK
- 0001861107
- Latest annual report
- 10-K · Feb 24, 2026
Companies similar to CeriBell
| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| BVSBioventus Inc. Class A | 12.77 | -2.52% | $872.26M | vs CBLL |
| SIBNSI-BONE Inc. | 19.10 | -2.30% | $856.03M | vs CBLL |
| PACBPacific Biosciences of California Inc. | 2.72 | +0.74% | $845.46M | vs CBLL |
| QDELQuidelOrtho Corporation | 12.31 | -2.07% | $844.16M | vs CBLL |
| BBNXBeta Bionics Inc. | 18.08 | -2.95% | $975.35M | vs CBLL |
| INMDInMode Ltd. | 14.01 | +0.14% | $806.19M | vs CBLL |
| IARTIntegra LifeSciences Holdings Corporation | 13.00 | -2.40% | $1.01B | vs CBLL |
| ENOVEnovis Corporation | 17.61 | -3.24% | $1.02B | vs CBLL |